Simic Mima, Stewart Catherine S, Konstantellou Anna, Hodsoll John, Eisler Ivan, Baudinet Julian
Maudsley Centre for Child and Adolescent Eating Disorders (MCCAED), Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE5 8AZ, UK.
Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
J Eat Disord. 2022 Feb 21;10(1):27. doi: 10.1186/s40337-022-00553-6.
Findings from randomised control trials inform the development of evidence-based eating disorder (ED) practice guidelines internationally. Only recently are data beginning to emerge regarding how these treatments perform outside of research settings. This study aimed to evaluate treatment pathways and outcomes for a specialist child and adolescent ED service across a five-year period.
All consecutive referrals between August 2009 and January 2014 seen at the Maudsley Centre for Child and Adolescent Eating Disorders in London were included. Data are reported on for all young people who were offered treatment (N = 357).
Most young people referred to the service were diagnosed with anorexia nervosa (AN)/Atypical AN (81%). Treatment for AN/Atypical AN (median 11 months) was predominantly ED focused family therapy (99%). Treatment for bulimia nervosa (BN)/Atypical BN (median seven months) was most commonly a combination of cognitive behavioural therapy and ED focused family therapy (87%). At discharge, 77% of the AN/Atypical AN group had a good or intermediate outcome and 59% of the BN/Atypical BN group reported no or fewer than weekly bulimic episodes. 27% of the AN/Atypical AN group had enhanced treatment with either day- and/or inpatient admissions (AIM group). The %mBMI at 3 months of treatment was strongest predictor of the need for treatment enhancement and more modestly EDE-Q and age at assessment. The AIM group at assessment had significantly lower weight, and higher ED and comorbid symptomatology and went on to have significantly longer treatment (16 vs. 10 months). At discharge, this group had significantly fewer good and more poor outcomes on the Morgan Russell criteria, but similar outcomes regarding ED and comorbid symptoms and quality of life. When analysis was adjusted for %mBMI at assessment, 1 and 3 months of treatment, differences in Morgan Russell outcomes and %mBMI were small and compatible with no difference in outcome by treatment group.
This study shows that outcomes in routine clinical practice in a specialist community-based service compare well to those reported in research trials. The finding from research trials that early weight gain is associated with improved outcomes was also replicated in this study. Enhancing outpatient treatment with day treatment and/or inpatient care is associated with favourable outcome for most of the young people, although a longer duration of treatment is required.
随机对照试验的结果为国际上基于证据的饮食失调(ED)实践指南的制定提供了依据。直到最近,关于这些治疗方法在研究环境之外的表现的数据才开始出现。本研究旨在评估一个专业儿童和青少年饮食失调服务机构在五年期间的治疗途径和结果。
纳入2009年8月至2014年1月期间在伦敦莫兹利儿童和青少年饮食失调中心连续就诊的所有转诊患者。报告了所有接受治疗的年轻人的数据(N = 357)。
转诊至该服务机构的大多数年轻人被诊断为神经性厌食症(AN)/非典型AN(81%)。AN/非典型AN的治疗(中位数11个月)主要是专注于饮食失调的家庭治疗(99%)。神经性贪食症(BN)/非典型BN的治疗(中位数7个月)最常见的是认知行为疗法和专注于饮食失调的家庭治疗相结合(87%)。出院时,77%的AN/非典型AN组有良好或中等结果,59%的BN/非典型BN组报告没有或每周的贪食发作次数少于一次。27%的AN/非典型AN组通过日间和/或住院治疗得到强化治疗(AIM组)。治疗3个月时的%mBMI是治疗强化需求的最强预测因素,在较小程度上也是EDE-Q和评估时的年龄的预测因素。评估时的AIM组体重明显较低,饮食失调和共病症状更严重,治疗时间也明显更长(16个月对10个月)。出院时,根据摩根·拉塞尔标准,该组的良好结果明显较少,不良结果较多,但在饮食失调、共病症状和生活质量方面的结果相似。当对评估时、治疗1个月和3个月时的%mBMI进行分析调整后,摩根·拉塞尔结果和%mBMI的差异很小,与治疗组之间结果无差异相符。
本研究表明,在一个专业的社区服务机构的常规临床实践中的结果与研究试验中报告的结果相当。本研究也重复了研究试验中的发现,即早期体重增加与更好的结果相关。对于大多数年轻人来说,通过日间治疗和/或住院护理强化门诊治疗与良好结果相关,尽管需要更长的治疗时间。